Industries > Pharma > Global Ablation Technologies Market Forecast 2019-2029
Global Ablation Technologies Market Forecast 2019-2029
Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, Musculoskeletal, Ophthalmology, Urology
The global ablation technologies market is expected to grow at a CAGR of 9.4% from 2017-2022 and CAGR of 9.7% from 2022-2027. The market is expected to grow at a CAGR of 9.5% from 2017 to 2027. The market is estimated at $3.3bn in 2016, and $9.05bn in 2026.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 212-page report you will receive 92 tables and 190 figures – all unavailable elsewhere.
The 212-page report provides clear detailed insight into the Global Ablation Technologies market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Revenue and growth forecasts to 2027 for the global ablation technologies market
• Revenue and growth forecasts to 2027 for the leading countries
• Revenue and growth forecasts to 2027 for the leading segments of the global ablation technologies market by technology and application.
• Revenue and growth forecasts to 2027 for the leading companies
Individual revenue forecasts to 2027 by technology, each submarket is further segmented by geography (North America, Europe, Asia-Pacific, and RoW):
• Radiofrequency
• Ultrasound
• Cyroablation
• Endometrial Hydrothermal
• Laser/light
• Electrical
• Microwave
Individual revenue forecasts to 2027 by application, each submarket is further segmented by geography (North America, Europe, Asia-Pacific, and RoW):
• Cardiovascular
• Oncology
• Musculoskeletal
• Ophthalmology
• Gynaecology
• Urology
• Other
Individual revenue forecasts to 2027 by country, each country is further segmented by technology:
• United States
• Canada
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
• China
• India
• Rest of APAC
• Rest of the World
Discussion and revenue forecasts to 2027 of the major players in the ablation technologies market:
• Medtronic Plc
• Biosense Water, Inc./Johnson & Johnson, Inc.
• St. Jude Medical, Inc.
• Boston Scientific Corporation
• Angiodynamics, Inc.
• Atricure, Inc.
• Conmed Corporation
• Olympus Corporation
• Smith & Nephew
Visiongain’s study is intended for anyone requiring commercial analyses for the Ablation Technologies market. You find data, trends and predictions.
Buy our report today Global Ablation Technologies Market Forecast 2019-2029: Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, Musculoskeletal, Ophthalmology, Urology.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global Ablation Technologies Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to the Ablation Technologies Market
2.1 Ablation Technologies Market Structure
2.2 Ablation Technologies Market Definition
2.3 Ablation Technologies Type Definition
2.3.1 Radiofrequency Ablation
2.3.2 Laser/light Ablation
2.3.3 Ultrasound Ablation
2.3.4 Electrical Ablation
2.3.5 Cryoablation
2.3.6 Microwave Ablation
2.3.7 Endometrial Hydrothermal Ablation
2.4 Introduction to Ablation Technologies Application
2.4.1 Cardiovascular
2.4.2 Oncology
2.4.3 Musculoskeletal
2.4.4 Ophthalmology
2.4.5 Gynaecology
2.4.6 Urology
2.4.7 Other
3. Global Ablation Technologies Market 2019-2029
3.1 Global Ablation Technologies Market Forecast 2019-2029
3.2 Global Ablation Technologies Drivers & Restraints 2016
3.2.1 Strengths
3.2.1.1 Rising incidence and prevalence of target diseases; cancer, cardiovascular diseases
3.2.1.2 New product launches /technological advancements
3.2.1.3 Availability of clinical evidences owing to massive on-going clinical trials
3.2.2 Weaknesses
3.2.2.1 Strategies by various government to curb the healthcare expenditure
4. Global Ablation Technologies Submarket Forecast 2019-2029
4.1 Global Ablation Technologies type Forecast 2019-2029
4.1.1 Radiofrequency
4.1.2 Laser/Light Ablation
4.1.3 Ultrasound Ablation
4.1.4 Electrical Ablation
4.1.5 Cryoablation
4.1.6 Microwave ablation
4.1.7 Endometrial Hydrothermal Ablation
4.2 Global Ablation Technologies Application Forecast 2019-2029
4.2.1 Cardiovascular
4.2.2 Oncology
4.2.3 Musculoskeletal
4.2.4 Ophthalmology
4.2.5 Gynaecology
4.2.6 Urology
4.2.7 Other
5. Leading Regional Ablation Technologies Market Forecast 2019-2029
5.1 Overview of Regional Ablation Technologies Market Forecast
5.2 North America Ablation Technologies Market by Country Forecast 2019-2029
5.2.1 US Ablation Technologies Market Forecast 2019-2029
5.2.1.1 US Ablation Technologies Market by Technology 2019-2029
5.2.2 Canada Ablation Technologies Market Forecast 2019-2029
5.2.2.1 Canada Ablation Technologies Market by Technology 2019-2029
5.3 Europe Ablation Technologies Market by Country Forecast 2019-2029
5.3.1 Germany Ablation Technologies Market Forecast 2019-2029
5.3.1.1 Germany Ablation Technologies Market by Technology 2019-2029
5.3.2 France Ablation Technologies Market Forecast 2019-2029
5.3.2.1 France Ablation Technologies Market by Technology 2019-2029
5.3.3 UK Ablation Technologies Market Forecast 2019-2029
5.3.3.1 UK Ablation Technologies Market by Technology 2019-2029
5.3.4 Italy Ablation Technologies Market Forecast 2019-2029
5.3.4.1 Italy Ablation Technologies Market by Technology 2019-2029
5.3.5 Spain Ablation Technologies Market Forecast 2019-2029
5.3.5.1 Spain Ablation Technologies Market by Technology 2019-2029
5.4 Asia-Pacific Ablation Technologies Market by Country Forecast 2019-2029
5.4.1 Japan Ablation Technologies Market Forecast 2019-2029
5.4.1.1 Japan Ablation Technologies Market by Technology 2019-2029
5.4.2 China Ablation Technologies Market Forecast 2019-2029
5.4.2.1 China Ablation Technologies Market by Technology 2019-2029
5.4.3 India Ablation Technologies Market Forecast 2019-2029
5.4.3.1 India Ablation Technologies Market by Technology 2019-2029
5.4.4 RoAPAC Ablation Technologies Market Forecast 2019-2029
5.4.4.1 RoAPAC Ablation Technologies Market by Technology 2019-2029
5.5 RoW Ablation Technologies Market Forecast 2019-2029
5.5.1 RoW Ablation Technologies Market by Technology 2019-2029
6. SWOT Analysis of the Ablation Technologies Market 2019-2029
7. Leading Ablation Technologies Companies
7.1 Medtronic plc
7.1.1 Introduction
7.1.2 Medtronic plc Total Company Sales 2012-2016
7.1.3 Medtronic plc Sales by Segment of Business 2012-2016
7.1.4 Medtronic plc Sales by Regional Segment of Business 2011-2015
7.1.5 Medtronic plc Ablation Technologies Selected Recent Programmes 2014-2015
7.1.6 Medtronic plc Analysis
7.2 BIOSENSE WEBSTER, INC.
7.2.1 Introduction
7.2.2 Johnson & Johnson Total Company Sales 2011-2015
7.2.3 Johnson & Johnson Sales by Segment of Business 2011-2015
7.2.4 Johnson & Johnson Sales by Regional Segment of Business 2011-2015
7.2.5 Johnson & Johnson Ablation Technologies Selected Recent Programmes 2011-2015
7.2.6 Biosense Webster, Inc. Analysis
7.3 St. Jude Medical, Inc.
7.3.1 Introduction
7.3.2 St. Jude Medical, Inc. Total Company Sales 2011-2015
7.3.3 St. Jude Medical, Inc. Sales by Segment of Business 2011-2015
7.3.4 St. Jude Medical, Inc. Sales by Regional Segment of Business 2011-2015
7.3.5 St. Jude Medical, Inc. Ablation Technologies Selected Recent Programmes 2011-2015
7.3.6 St. Jude Medical, Inc. Analysis
7.4 Boston Scientific Corporation
7.4.1 Introduction
7.4.2 Boston Scientific Corporation Total Company Sales 2011-2015
7.4.3 Boston Scientific Corporation Sales by Segment of Business 2011-2015
7.4.4 Boston Scientific Corporation Sales by Regional Segment of Business 2011-2015
7.4.5 Boston Scientific Corporation Ablation Technologies Selected Recent Programmes 2011-2015
7.4.6 Boston Scientific Corporation Analysis
7.5 AngioDynamics, Inc.
7.5.1 Introduction
7.5.2 AngioDynamics, Inc. Total Company Sales 2012-2016
7.5.3 AngioDynamics, Inc. Sales by Segment of Business 2011-2015
7.5.4 AngioDynamics, Inc. Sales by Regional Segment of Business 2011-2015
7.5.5 AngioDynamics, Inc. Ablation Technologies Selected Recent Programmes 2011-2015
7.6 AtriCure, Inc.
7.6.1 Introduction
7.6.1 AtriCure, Inc. Total Company Sales 2011-2015
7.6.2 AtriCure, Inc. Sales by Segment of Business 2011-2015
7.6.3 AtriCure, Inc. Sales by Regional Segment of Business 2011-2015
7.6.4 AtriCure, Inc. Ablation Technologies Selected Recent Programmes 2011-2015
7.7 CONMED Corporation
7.7.1 Introduction
7.7.2 CONMED Corporation Total Company Sales 2011-2015
7.7.3 CONMED Corporation Sales by Segment of Business 2011-2015
7.7.4 CONMED Corporation Sales by Regional Segment of Business 2011-2015
7.7.5 CONMED Corporation Ablation Technologies Selected Recent Programmes 2011-2015
7.8 Olympus Corporation
7.8.1 Introduction
7.8.2 Olympus Corporation Total Company Sales 2011-2015
7.8.3 Olympus Corporation Sales by Segment of Business 2011-2015
7.8.4 Olympus Corporation Sales by Regional Segment of Business 2012-2016
7.8.5 Olympus Corporation Ablation Technologies Selected Recent Programmes 2011-2015
7.9 Smith & Nephew
7.9.1 Introduction
7.9.2 SMITH & NEPHEW Total Company Sales 2011-2015
7.9.3 SMITH & NEPHEW Sales by Segment of Business 2011-2015
7.9.4 SMITH & NEPHEW Sales by Regional Segment of Business 2011-2015
7.9.5 SMITH & NEPHEW Ablation Technologies Selected Recent Programmes 2011-2015
8. Conclusions and Recommendations
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Figures
Figure 2.1 Global Ablation Technologies Market Segmentation Overview
Figure 3.1 Global Ablation Technologies Market Forecast 2019-2029 ($m, Global AGR %)
Figure 4.1 Global Ablation Technologies Type Submarket AGR Forecast 2019-2029 (AGR %)
Figure 4.2 Global Ablation Technologies Type Submarket Market Forecast 2019-2029 ($m, Global AGR %)
Figure 4.3 Global Ablation Technologies Type Submarket Shares 2017 (% Share)
Figure 4.4 Global Ablation Technologies Type Submarket Shares 2022 (% Share)
Figure 4.5 Global Ablation Technologies Type Submarket Shares 2027 (% Share)
Figure 4.6 Global Ablation Technologies Radiofrequency Market Forecast by Regional Market 2019-2029($m)
Figure 4.7 Global Ablation Technologies Radiofrequency Market Share by Region 2017 (% Share)
Figure 4.8 Global Ablation Technologies Radiofrequency Market Share by Region 2022 (% Share)
Figure 4.9 Global Ablation Technologies Radiofrequency Market Share by Region 2027 (% Share)
Figure 4.10 Global Ablation Technologies Laser/Light Market Forecast by Regional Market 2019-2029 ($m)
Figure 4.11 Global Ablation Technologies Laser/Light Market Share by Region 2017 (% Share)
Figure 4.12 Global Ablation Technologies Laser/Light Market Share by Region 2022 (% Share)
Figure 4.13 Global Ablation Technologies Laser/Light Market Share by Region 2027 (% Share)
Figure 4.14 Global Ablation Technologies Ultrasound Market Forecast ($m) by Regional Market, 2019-2029
Figure 4.15 Global Ablation Technologies Ultrasound Market Share by Region 2017 (% Share)
Figure 4.16 Global Ablation Technologies Ultrasound Market Share by Region 2022 (% Share)
Figure 4.17 Global Ablation Technologies Ultrasound Market Share by Region 2027 (% Share)
Figure 4.18 Global Ablation Technologies Electrical Market Forecast ($m) by Regional Market, 2019-2029
Figure 4.19 Global Ablation Technologies Electrical Market Share by Region 2017 (% Share)
Figure 4.20 Global Ablation Technologies Electrical Market Share by Region 2022 (% Share)
Figure 4.21 Global Ablation Technologies Electrical Market Share by Region 2027 (% Share)
Figure 4.22 Global Ablation Technologies Cryoablation Market Forecast by Regional Market 2019-2029 ($m)
Figure 4.23 Global Ablation Technologies Cryoablation Market Share by Region 2017 (% Share)
Figure 4.24 Global Ablation Technologies Cryoablation Market Share by Region 2022 (% Share)
Figure 4.25 Global Ablation Technologies Cryoablation Market Share by Region 2027 (% Share)
Figure 4.26 Global Ablation Technologies Microwave Market Forecast ($m) by Regional Market, 2019-2029
Figure 4.27 Global Ablation Technologies Microwave Market Share by Region 2017 (% Share)
Figure 4.28 Global Ablation Technologies Microwave Market Share by Region 2022 (% Share)
Figure 4.29 Global Ablation Technologies Microwave Market Share by Region 2027 (% Share)
Figure 4.30 Global Ablation Technologies Endometrial Hydrothermal Market Forecast ($m) by Regional Market, 2019-2029
Figure 4.31 Global Ablation Technologies Endometrial Hydrothermal Market Share by Region 2017 (% Share)
Figure 4.32 Global Ablation Technologies Endometrial Hydrothermal Market Share by Region 2022 (% Share)
Figure 4.33 Global Ablation Technologies Endometrial Hydrothermal Market Share by Region 2027 (% Share)
Figure 4.34 Global Ablation Technologies Application Submarket AGR Forecast 2019-2029 (AGR %)
Figure 4.35 Global Ablation Technologies Application Submarket Market Forecast 2019-2029 ($m, Global AGR %)
Figure 4.36 Global Ablation Technologies Application submarket Shares 2017 (% Share)
Figure 4.37 Global Ablation Technologies Application submarket Shares 2022 (% Share)
Figure 4.38 Global Ablation Technologies Application submarket Shares 2027 (% Share)
Figure 4.39 Global Ablation Technologies Cardiovascular Market Forecast by Regional Market 2019-2029($m)
Figure 4.40 Global Ablation Technologies Cardiovascular Market Share by Region 2017 (% Share)
Figure 4.41 Global Ablation Technologies Cardiovascular Market Share by Region 2022 (% Share)
Figure 4.42 Global Ablation Technologies Cardiovascular Market Share by Region 2027 (% Share)
Figure 4.43 Global Ablation Technologies Oncology Market Forecast ($m) by Regional Market, 2019-2029
Figure 4.44 Global Ablation Technologies Oncology Market Share by Region 2017 (% Share)
Figure 4.45 Global Ablation Technologies Oncology Market Share by Region 2022 (% Share)
Figure 4.46 Global Ablation Technologies Oncology Market Share by Region 2027 (% Share)
Figure 4.47 Global Ablation Technologies Musculoskeletal Market Forecast ($m) by Regional Market 2019-2029
Figure 4.48 Global Ablation Technologies Musculoskeletal Market Share by Region 2017 (% Share)
Figure 4.49 Global Ablation Technologies Musculoskeletal Market Share by Region 2022 (% Share)
Figure 4.50 Global Ablation Technologies Musculoskeletal Market Share by Region 2027 (% Share)
Figure 4.51 Global Ablation Technologies Ophthalmology Market Forecast by Regional Market 2019-2029($m)
Figure 4.52 Global Ablation Technologies Ophthalmology Market Share by Region 2017 (% Share)
Figure 4.53 Global Ablation Technologies Ophthalmology Market Share by Region 2022 (% Share)
Figure 4.54 Global Ablation Technologies Ophthalmology Market Share by Region 2027 (% Share)
Figure 4.55 Global Ablation Technologies Gynecology Market Forecast ($m) by Regional Market, 2019-2029
Figure 4.23 Global Ablation Technologies Gynecology Market Share by Region 2017 (% Share)
Figure 4.56 Global Ablation Technologies Gynecology Market Share by Region 2022 (% Share)
Figure 4.57 Global Ablation Technologies Gynecology Market Share by Region 2027 (% Share)
Figure 4.58 Global Ablation Technologies Urology Market Forecast by Regional Market 2019-2029($ m)
Figure 4.59 Global Ablation Technologies Urology Market Share by Region 2017 (% Share)
Figure 4.60 Global Ablation Technologies Urology Market Share by Region 2022 (% Share)
Figure 4.61 Global Ablation Technologies Urology Market Share by Region 2027 (% Share)
Table 4.62 Global Ablation Technologies Other Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Figure 4.63 Global Ablation Technologies Other Market Forecast by Regional Market 2019-2029($ m)
Figure 4.64 Global Ablation Technologies Other Market Share by Region 2017 (% Share)
Figure 4.65 Global Ablation Technologies Other Market Share by Region 2022 (% Share)
Figure 4.66 Global Ablation Technologies Other Market Share by Region 2027 (% Share)
Figure 5.1 Global Ablation Technologies Market Forecast 2019-2029 ($m, Global AGR %)
Figure 5.2 Leading Regional Ablation Technologies Testing Market AGR Forecast 2016-2026 (AGR %)
Figure 5.3 Leading Regional Ablation Technologies Market Share by Region 2017 (% Share)
Figure 5.4 Leading Regional Ablation Technologies Market Share by Region 2022 (% Share)
Figure 5.5 Leading Regional Ablation Technologies Market Share by Region 2027 (% Share)
Figure 5.6 North America Ablation Technologies Market by Country 2019-2029 ($m, Global AGR %)
Figure 5.7 North America Ablation Technologies Market Share by Region 2017 (% Share)
Figure 5.8 North America Ablation Technologies Market Share by Region 2022 (% Share)
Figure 5.9 North America Ablation Technologies Market Share by Region 2027 (% Share)
Figure 5.10 US Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.11 US Ablation Technologies Market Share 2017 (% Share)
Figure 5.12 US Ablation Technologies Market Share 2022 (% Share)
Figure 5.13 US Ablation Technologies Market Share 2027 (% Share)
Figure 5.14 US Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.15 Canada Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.16 Canada Ablation Technologies Market Share 2017 (% Share)
Figure 5.17 Canada Ablation Technologies Market Share 2022 (% Share)
Figure 5.18 Canada Ablation Technologies Market Share 2027 (% Share)
Figure 5.19 Canada Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.20 Europe Ablation Technologies Market by Country 2019-2029 ($m, Global AGR %)
Figure 5.21 Europe Ablation Technologies Market Share by Region 2017 (% Share)
Figure 5.22 Europe Ablation Technologies Market Share by Region 2022 (% Share)
Figure 5.23 Europe Ablation Technologies Market Share by Region 2027 (% Share)
Figure 5.24 Germany Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.25 Germany Ablation Technologies Market Share 2017 (% Share)
Figure 5.26 Germany Ablation Technologies Market Share 2022 (% Share)
Figure 5.27 Germany Ablation Technologies Market Share 2027 (% Share)
Figure 5.28 Germany Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.29 France Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.30 France Ablation Technologies Market Share 2017 (% Share)
Figure 5.31 France Ablation Technologies Market Share 2022 (% Share)
Figure 5.32 France Ablation Technologies Market Share 2027 (% Share)
Figure 5.33 UK Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.34 UK Ablation Technologies Market Share 2017 (% Share)
Figure 5.35 UK Ablation Technologies Market Share 2022 (% Share)
Figure 5.36 UK Ablation Technologies Market Share 2027 (% Share)
Figure 5.37 UK Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.38 Italy Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.39 Italy Ablation Technologies Market Share 2017 (% Share)
Figure 5.40 Italy Ablation Technologies Market Share 2022 (% Share)
Figure 5.41 Italy Ablation Technologies Market Share 2027 (% Share)
Figure 5.42 Italy Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.43 Spain Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.44 Spain Ablation Technologies Market Share 2017 (% Share)
Figure 5.45 Spain Ablation Technologies Market Share 2022 (% Share)
Figure 5.46 Spain Ablation Technologies Market Share 2027 (% Share)
Figure 5.47 Spain Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.48 Asia-Pacific Ablation Technologies Market by Country 2019-2029 ($m, Global AGR %)
Figure 5.49 Asia-Pacific Ablation Technologies Market Share 2017 (% Share)
Figure 5.50 Asia-Pacific Ablation Technologies Market Share 2022 (% Share)
Figure 5.51 Asia-Pacific Ablation Technologies Market Share 2027 (% Share)
Figure 5.52 Japan Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.53 Japan Ablation Technologies Market Share 2017 (% Share)
Figure 5.54 Japan Ablation Technologies Market Share 2022 (% Share)
Figure 5.55 Japan Ablation Technologies Market Share 2027 (% Share)
Figure 5.56 Japan Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.57 China Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.58 China Ablation Technologies Market Share 2017 (% Share)
Figure 5.59 China Ablation Technologies Market Share 2022 (% Share)
Figure 5.60 China Ablation Technologies Market Share 2027 (% Share)
Figure 5.61 India Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.62 India Ablation Technologies Market Share 2017 (% Share)
Figure 5.63 India Ablation Technologies Market Share 2022 (% Share)
Figure 5.64 India Ablation Technologies Market Share 2027 (% Share)
Figure 5.65 India Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.66 RoAPAC Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.67 RoAPAC Ablation Technologies Market Share 2017 (% Share)
Figure 5.68 RoAPAC Ablation Technologies Market Share 2022 (% Share)
Figure 5.69 RoAPAC Ablation Technologies Market Share 2027 (% Share)
Figure 5.70 RoAPAC Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 5.71 RoW Ablation Technologies Market 2019-2029 ($m, AGR %)
Figure 5.72 RoW Ablation Technologies Market Share 2017 (% Share)
Figure 5.73 RoW Ablation Technologies Market Share 2022 (% Share)
Figure 5.74 RoW Ablation Technologies Market Share 2027 (% Share)
Figure 5.75 RoW Ablation Technologies Market by Technology 2019-2029 ($m)
Figure 7.1 Medtronic plc Total Company Sales 2012-2016 ($m, AGR %)
Figure 7.2 Medtronic plc Sales by Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.3 Medtronic plc Sales AGR by Segment of Business 2013-2016 (AGR %)
Figure 7.4 Medtronic plc Sales by Regional Segment of Business 2012-2016($m, Total Company Sales AGR %)
Figure 7.5 Medtronic plc Sales AGR by Regional Segment of Business 2013-2016 (AGR %)
Figure 7.6 Johnson & Johnson Total Company Sales 2011-2015 ($m, AGR %)
Figure 7.7 Johnson & Johnson Sales by Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.8 Johnson & Johnson Sales AGR by Segment of Business 2012-2015 (AGR %)
Figure 7.9 Johnson & Johnson Sales by Regional Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.10 Johnson & Johnson Sales AGR by Regional Segment of Business 2012-2015 (AGR %)
Figure 7.11 St. Jude Medical, Inc. Total Company Sales 2011-2015 ($m, AGR %)
Figure 7.12 St. Jude Medical, Inc. Sales by Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.13 St. Jude Medical, Inc. Sales AGR by Segment of Business 2012-2015 (AGR %)
Figure 7.14 St. Jude Medical, Inc. Sales by Regional Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.15 St. Jude Medical, Inc. Sales AGR by Regional Segment of Business 2012-2015 (AGR %)
Figure 7.16 Boston Scientific Corporation Total Company Sales 2011-2015 ($m, AGR %)
Figure 7.17 Boston Scientific Corporation Sales by Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.18 Boston Scientific Corporation Sales by Regional Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.19 Boston Scientific Corporation Sales AGR by Regional Segment of Business 2012-2015 (AGR %)
Figure 7.20 AngioDynamics, Inc. Total Company Sales 2012-2016 ($m, AGR %)
Figure 7.21 AngioDynamics, Inc. Sales by Segment of Business 2012-2016 ($m, Total Company Sales AGR %)
Figure 7.22 AngioDynamics, Inc. Sales AGR by Segment of Business 2013-2016 (AGR %)
Figure 7.23 AngioDynamics, Inc. Sales by Regional Segment of Business 2012-2016 ($m, Total Company Sales AGR %)
Figure 7.24 AngioDynamics, Inc. Sales AGR by Regional Segment of Business 2013-2016 (AGR %)
Figure 7.25 AtriCure, Inc. Total Company Sales 2011-2015 ($m, AGR %)
Figure 7.26 AtriCure, Inc. Sales by Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.27 AtriCure, Inc. Sales AGR by Segment of Business 2012-2015 (AGR %)
Figure 7.28 AtriCure, Inc. Sales by Regional Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.29 AtriCure, Inc. Sales AGR by Regional Segment of Business 2012-2015 (AGR %)
Figure 7.30 CONMED Corporation Total Company Sales 2011-2015 ($m, AGR %)
Figure 7.31 CONMED Corporation Sales by Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.32 CONMED Corporation Sales AGR by Segment of Business 2012-2015 (AGR %)
Figure 7.33 CONMED Corporation Sales by Regional Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.34 CONMED Corporation Sales AGR by Regional Segment of Business 2012-2015 (AGR %)
Figure 7.35 Olympus Corporation Total Company Sales 2011-2015 ($m, AGR %)
Figure 7.36 Olympus Corporation Sales by Segment of Business 2012-2016 ($m, Total Company Sales AGR %)
Figure 7.37 Olympus Corporation Sales AGR by Segment of Business 2013-2016 (AGR %)
Figure 7.38 Olympus Corporation Sales by Regional Segment of Business 2012-2016 ($m, Total Company Sales AGR %)
Figure 7.39 Olympus Corporation Sales AGR by Regional Segment of Business 2013-2016 (AGR %)
Figure 7.40 SMITH & NEPHEW Total Company Sales 2011-2015 ($m, AGR %)
Figure 7.41 SMITH & NEPHEW Sales by Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.42 SMITH & NEPHEW Sales AGR by Segment of Business 2012-2015 (AGR %)
Figure 7.43 SMITH & NEPHEW Sales by Regional Segment of Business 2011-2015 ($m, Total Company Sales AGR %)
Figure 7.44 SMITH & NEPHEW Sales AGR by Regional Segment of Business 2012-2015 (AGR %)
Figure 8.1 Global Ablation Technologies Type Market Comparison 2019-2029 ($m)
Figure 8.2 Global Ablation Technologies Application Market Comparison 2019-2029 ($m)
List of Tables
Table 3.1 Global Ablation Technologies Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 3.2 Global Ablation Technologies Market Drivers & Restraints 2016
Table 4.1 Global Ablation Technologies type Submarket Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.2 Global Ablation Technologies Radiofrequency Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.3 Global Ablation Technologies Laser/Light Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.4 Global Ablation Technologies Ultrasound Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.5 Global Ablation Technologies Electrical Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.6 Global Ablation Technologies Cryoablation Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.7 Global Ablation Technologies Microwave Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.8 Global Ablation Endometrial Hydrothermal Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.9 Global Ablation Technologies Application Submarket Market Forecast 2019-2029 ($m, AGR %)
Table 4.10 Global Ablation Technologies Cardiovascular Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.11 Global Ablation Technologies Oncology Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.12 Global Ablation Technologies Musculoskeletal Submarket by Regional Market Forecast 2019-2029 ($ m, AGR %, CAGR %)
Table 4.13 Global Ablation Technologies Ophthalmology Submarket by Regional Market Forecast 2019-2029 ($m, AGR %, CAGR %)
Table 4.14 Global Ablation Technologies Gynecology Submarket by Regional Market Forecast 2019-2029 ($ m, AGR %, CAGR %)
Table 4.15 Global Ablation Technologies Urology Submarket by Regional Market Forecast 2019-2029 ($ m, AGR %, CAGR %)
Table 5.1 Leading Regional Ablation Technologies Market Forecasts 2019-2029 ($m, Global AGR %, CAGR %)
Table 5.2 North America Ablation Technologies Market by Country 2019-2029 ($m, AGR %, CAGR %)
Table 5.3 US Ablany Sales 2012-2016 ($m, AGR %)
Table 7.14 St. Jude Medical, Inc. Sales by Segment of Business 2012-2016 ($m, AGR %)
Table 7.15 St. Jude Medical, Inc. Sales by Regional Segment of Business 2011-2015 ($m, AGR %)
Table 7.16 Selected Recent St. Jude Medical, Inc. Ablation Technologies Programmes 2011-2015 (Date, Programme Type, Details)
Table 7.16 Boston Scientific Corporation (CEO, Total Company Sales $m, Net Income $m, HQ, Founded, No. of Employees, Ticker, Website)
Table 7.17 Boston Scientific Corporation Total Company Sales 2012-2016 ($m, AGR %)
Table 7.18 Boston Scientific Corporation Sales by Segment of Business 2012-2016 ($m, AGR %)
Table 7.19 Boston Scientific Corporation Sales by Regional Segment of Business 2011-2015 ($m, AGR %)
Table 7.20 Selected Recent Boston Scientific Corporation Ablation Technologies Programmes 2011-2015 (Date, Programme Type, Details)
Table 7.21 AngioDynamics, Inc. (CEO, Total Company Sales $m, Net Income $m, HQ, Founded, No. of Employees, Ticker, Website)
Table 7.22 AngioDynamics, Inc. Total Company Sales 2012-2016 ($m, AGR %)
Table 7.23 AngioDynamics, Inc. Sales by Segment of Business 2012-2016 ($m, AGR %)
Table 7.24 AngioDynamics, Inc. Sales by Regional Segment of Business 2011-2015 ($m, AGR %)
Table 7.25 Selected Recent AngioDynamics, Inc. Ablation Technologies Programmes 2011-2015 (Date, Programme Type, Details)
Table 7.26 AtriCure, Inc. (CEO, Total Company Sales $m, Net Income $m, HQ, Founded, No. of Employees, Ticker, Website)
Table 7.27 AtriCure, Inc. Total Company Sales 2012-2016 ($m, AGR %)
Table 7.28 AtriCure, Inc. Sales by Segment of Business 2012-2016 ($m, AGR %)
Table 7.29 AtriCure, Inc. Sales by Regional Segment of Business 2011-2015 ($m, AGR %)
Table 7.30 Selected Recent AtriCure, Inc. Ablation Technologies Programmes 2011-2015 (Date, Programme Type, Details)
Table 7.31 CONMED Corporation (CEO, Total Company Sales $m, Net Income $m, HQ, Founded, No. of Employees, Ticker, Website)
Table 7.32 CONMED Corporation Total Company Sales 2012-2016 ($m, AGR %)
Table 7.33 CONMED Corporation Sales by Segment of Business 2012-2016 ($m, AGR %)
Table 7.34 CONMED Corporation Sales by Regional Segment of Business 2011-2015 ($m, AGR %)
Table 7.35 Selected Recent CONMED Corporation Ablation Technologies Programmes 2011-2015 (Date, Programme Type, Details)
Table 7.36 Olympus Corporation (CEO, Total Company Sales $m, Net Income $m, HQ, Founded, No. of Employees, Ticker, Website)
Table 7.37 Olympus Corporation Total Company Sales 2012-2016 ($m, AGR %)
Table 7.38 Olympus Corporation Sales by Segment of Business 2012-2016 ($m, AGR %)
Table 7.39 Olympus Corporation Sales by Regional Segment of Business 2012-2016 ($m, AGR %)
Table 7.40 Selected Recent Olympus Corporation Ablation Technologies Programmes 2011-2015 (Date, Programme Type, Details)
Table 7.41 SMITH & NEPHEW (CEO, Total Company Sales $m, Net Income $m, HQ, Founded, No. of Employees, Ticker, Website)
Table 7.42 SMITH & NEPHEW Total Company Sales 2012-2016 ($m, AGR %)
Table 7.43 SMITH & NEPHEW Sales by Segment of Business 2012-2016 ($m, AGR %)
Table 7.44 SMITH & NEPHEW Sales by Regional Segment of Business 2011-2015 ($m, AGR %)
Table 7.45 Selected Recent SMITH & NEPHEW Ablation Technologies Programmes 2011-2015 (Date, Programme Type, Details)
Active Medical, Inc.
AngioDynamics, Inc.
Aspen Laboratories
AtriCure, Inc.
Barcapel Foundation
Biosense Webster, Inc.
Boston Scientific Corporation
British Association of Aesthetic Plastic Surgeons (BAAPS)
BSD Medical Corporation
C.R. Bard
Cosman medical, Inc.
Covidien
DFINE, Inc.
Endosense SA
Ethicon
Food and Drug Administration (FDA)
Galil medical, Inc.
Johnson & Johnson
Linvatec Canada ULC
Macmillan Cancer Support
Medtronic
Microsulis Medical Ltd.
Monteris Medical
National Institute of Health Research (NIHR)
nContact, Inc.
NeuroTherm, Inc.
NeuWave Medical, Inc.
NxThera, Inc.
Olympus Corporation
Perseon Corporation
Profound Medical Corp.
Royal Brompton & Harefield NHS Foundation Trust
Royal Philips
Shandong Provincial Hospital
Smith & Nephew
SonaCare Medical
St Jude Medical
Terumo Europe
The American Heart Association
Trod Medical N.V.
University College London
Download sample pages
Complete the form below to download your free sample pages for Global Ablation Technologies Market Forecast 2019-2029Related reports
Global Medical Device Contract Manufacturing Market Forecast 2019-2029
The global medical device contract manufacturing market was valued at $75.84bn in 2018. Visiongain forecasts this market to increase to...Full DetailsPublished: 06 August 2019Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029
The global pulmonary/respiratory drug delivery market reached $40.67 bn in 2018 and is expected to grow at a CAGR of...
Full DetailsPublished: 29 May 2019The Ophthalmic Equipment Market Forecast 2019-2029
Ophthalmology is a branch of medical sciences that deals with the anatomical and physiological study of eyes such as function,...Full DetailsPublished: 31 May 2019Global Urology Devices Market Forecast 2019-2029
In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1%...
Full DetailsPublished: 21 May 2019The Global ENT (Ear, Nose and Throat) Devices Market Forecast 2019-2029
Our 145-page report provides 129 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry...
Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Global Ablation Technologies Market Forecast 2019-2029Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Latest Pharma news
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023